Bioactive Natural Antivirals: An Updated Review of the Available Plants and Isolated Molecules

Molecules. 2020 Oct 22;25(21):4878. doi: 10.3390/molecules25214878.

Abstract

Viral infections and associated diseases are responsible for a substantial number of mortality and public health problems around the world. Each year, infectious diseases kill 3.5 million people worldwide. The current pandemic caused by COVID-19 has become the greatest health hazard to people in their lifetime. There are many antiviral drugs and vaccines available against viruses, but they have many disadvantages, too. There are numerous side effects for conventional drugs, and active mutation also creates drug resistance against various viruses. This has led scientists to search herbs as a source for the discovery of more efficient new antivirals. According to the World Health Organization (WHO), 65% of the world population is in the practice of using plants and herbs as part of treatment modality. Additionally, plants have an advantage in drug discovery based on their long-term use by humans, and a reduced toxicity and abundance of bioactive compounds can be expected as a result. In this review, we have highlighted the important viruses, their drug targets, and their replication cycle. We provide in-depth and insightful information about the most favorable plant extracts and their derived phytochemicals against viral targets. Our major conclusion is that plant extracts and their isolated pure compounds are essential sources for the current viral infections and useful for future challenges.

Keywords: COVID-19; HIV; HSV; Hepatitis C virus; influenza virus; phytochemicals; plant extracts.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / chemistry
  • Antiviral Agents / classification
  • Antiviral Agents / isolation & purification
  • Antiviral Agents / therapeutic use*
  • Betacoronavirus / drug effects
  • Betacoronavirus / pathogenicity
  • Betacoronavirus / physiology
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / pathology
  • Coronavirus Infections / virology
  • Drug Discovery
  • HIV / drug effects
  • HIV / pathogenicity
  • HIV / physiology
  • HIV Infections / drug therapy*
  • HIV Infections / pathology
  • HIV Infections / virology
  • Hepacivirus / drug effects
  • Hepacivirus / pathogenicity
  • Hepacivirus / physiology
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / pathology
  • Hepatitis C, Chronic / virology
  • Herpes Simplex / drug therapy*
  • Herpes Simplex / pathology
  • Herpes Simplex / virology
  • Humans
  • Influenza, Human / drug therapy*
  • Influenza, Human / pathology
  • Influenza, Human / virology
  • Orthomyxoviridae / drug effects
  • Orthomyxoviridae / pathogenicity
  • Orthomyxoviridae / physiology
  • Pandemics
  • Phytochemicals / chemistry
  • Phytochemicals / classification
  • Phytochemicals / isolation & purification
  • Phytochemicals / therapeutic use*
  • Plants, Medicinal
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / pathology
  • Pneumonia, Viral / virology
  • SARS-CoV-2
  • Simplexvirus / drug effects
  • Simplexvirus / pathogenicity
  • Simplexvirus / physiology
  • Virus Internalization / drug effects
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • Phytochemicals